Historical review from 2026-09-07. Current price and availability are unconfirmed; check the original marketplace.
Insect Bite ID generates $2.8K/mo revenue with an exceptional 99.99% profit margin and a highly attractive 2.2x annual profit multiple. The AI-native business model and verified financials on TrustMRR are genuine strengths. However, the score reflects material open questions: no disclosed customer count, retention rate, user acquisition channel durability, or revenue growth trajectory—all critical to assessing whether this is sustainable recurring revenue or early-stage adoption with churn risk. The margin is unusually high for a consumer app, which warrants confirmation of whether this represents true profitability or incomplete cost accounting.
The software itself—a photo classifier with confidence scoring and bite-tracking database—can be built in 6 weeks using OpenAI's vision API, React Native, Firebase, and a simple Node.js backend, costing $4.5K–$8K in cash (AI subscription $15–30/mo included). However, the acquired asset is $2.8K/mo verified revenue with 99.99% margins and no disclosed churn—this represents real customer traction and immediate cash flow. The core acquisition decision rests on whether the buyer believes the user base, retention, and organic discovery are genuine and durable. Given the missing customer-count and retention data, build confidence is moderate; the verified margin and low multiple tilt the decision to buy, but only if the seller can confirm customer stickiness and cost completeness. A conservative buyer with margin-of-safety discipline might demand stronger evidence before committing $75K.
Cash estimate includes the AI tools, APIs and infrastructure needed for a solo founder to recreate the software. Build time is informational and lightly weighted. The verdict is driven mainly by customers, users, verified earnings, retention, distribution, brand, data and operating history.
Snap a photo to identify insect bites in seconds with AI. Get confidence scores, bite care advice, and track bites over time for extra peace of mind.
Opens the original listing on TrustMRR
Get new listings with asking prices, monthly profit, deal scores, and key risks.
The best reviewed deals, concise and evidence-first. Unsubscribe anytime.
Preliminary screening based on marketplace and public data. Verify all financial, legal, technical, customer, and operational claims independently before making an acquisition decision. This is not financial or legal advice.